Rapid generation of markerless recombinant MVA vaccines by en passant recombineering of a self-excising bacterial artificial chromosome.
The non-replicating poxviral vector modified vaccinia virus Ankara (MVA) is currently a leading candidate for development of novel recombinant vaccines against globally important diseases. The 1980s technology for making recombinant MVA (and other poxviruses) is powerful and robust, but relies on ra...
Príomhchruthaitheoirí: | Cottingham, MG, Gilbert, S |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2010
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
de réir: Cottingham, M, et al.
Foilsithe / Cruthaithe: (2008) -
Recombination-mediated genetic engineering of a bacterial artificial chromosome clone of modified vaccinia virus Ankara (MVA).
de réir: Matthew G Cottingham, et al.
Foilsithe / Cruthaithe: (2008-02-01) -
Correction: Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA).
de réir: Matthew G. Cottingham, et al.
Foilsithe / Cruthaithe: (2011-01-01) -
Generation of recombinant MVA-norovirus: a comparison study of bacterial artificial chromosome- and marker-based systems
de réir: Franziska Kugler, et al.
Foilsithe / Cruthaithe: (2019-08-01) -
Generation of multivalent recombinant MVA vaccines for malaria
de réir: Orubu, T
Foilsithe / Cruthaithe: (2012)